[go: up one dir, main page]

MX2010003071A - Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor. - Google Patents

Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor.

Info

Publication number
MX2010003071A
MX2010003071A MX2010003071A MX2010003071A MX2010003071A MX 2010003071 A MX2010003071 A MX 2010003071A MX 2010003071 A MX2010003071 A MX 2010003071A MX 2010003071 A MX2010003071 A MX 2010003071A MX 2010003071 A MX2010003071 A MX 2010003071A
Authority
MX
Mexico
Prior art keywords
pain
phenylamides
sulfonyl
substituted
treatment
Prior art date
Application number
MX2010003071A
Other languages
English (en)
Inventor
Karl Rudolphi
Martin Michaelis
Hans Guehring
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MX2010003071A publication Critical patent/MX2010003071A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invenci?n se refiere al uso de N-fenilamidas de ?cido 2- sulfonilaminobenzoico sustituidas con sulfonilo de f?rmula I, en la que A y R1 a R6 tienen los significados indicados en las reivindicaciones, para tratar el dolor y para fabricar un medicamento para el tratamiento del dolor.
MX2010003071A 2007-10-05 2008-09-20 Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor. MX2010003071A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07019521 2007-10-05
US1525607P 2007-12-20 2007-12-20
EP08013725 2008-07-31
PCT/EP2008/007953 WO2009043495A1 (en) 2007-10-05 2008-09-20 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain

Publications (1)

Publication Number Publication Date
MX2010003071A true MX2010003071A (es) 2010-04-01

Family

ID=40042693

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003071A MX2010003071A (es) 2007-10-05 2008-09-20 Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor.

Country Status (16)

Country Link
US (1) US8518998B2 (es)
EP (1) EP2207541B1 (es)
JP (1) JP5487107B2 (es)
KR (1) KR20100063109A (es)
CN (1) CN101815514B (es)
AR (1) AR071049A1 (es)
BR (1) BRPI0817483A2 (es)
CA (1) CA2706241C (es)
CL (1) CL2008002942A1 (es)
ES (1) ES2527948T3 (es)
IL (1) IL204668A (es)
MX (1) MX2010003071A (es)
PA (1) PA8797801A1 (es)
PE (1) PE20090961A1 (es)
TW (1) TW200932247A (es)
WO (1) WO2009043495A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569339B2 (en) 2011-03-10 2013-10-29 Boehringer Ingelheim International Gmbh Soluble guanylate cyclase activators
JP5826393B2 (ja) 2011-08-12 2015-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 可溶性グアニル酸シクラーゼ活性化因子
PL2892891T3 (pl) * 2012-09-07 2020-01-31 Boehringer Ingelheim International Gmbh Alkoksypirazole jako aktywatory rozpuszczalnej cyklazy guanylanowej
WO2014151953A1 (en) * 2013-03-15 2014-09-25 The California Institute For Biomedical Research Compounds and methods for inducing chondrogenesis
SG10201806565SA (en) 2014-07-22 2018-08-30 Boehringer Ingelheim Int Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
EP2990403A1 (en) 2014-08-29 2016-03-02 Novartis Tiergesundheit AG Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
CN104892466B (zh) * 2015-04-30 2018-05-29 中国科学技术大学 一种苯胺磺酰类化合物的合成及其作为hiv病毒抑制剂的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US684287A (en) 1900-03-15 1901-10-08 Millhiser Mfg Company Bag-stringing machine.
JP3786579B2 (ja) 1998-07-08 2006-06-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 硫黄置換スルホニルアミノカルボン酸ｎ−アリールアミド、それらの製造、それらの使用、及びそれらを含む医薬製剤
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
DE19943634A1 (de) * 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10122894A1 (de) * 2001-05-11 2002-11-14 Bayer Ag Neue Sulfonat-substituierte Pyrazolopyridinderivate
DOP2003000556A (es) * 2002-01-23 2003-10-31 Warner Lambert Co Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico.
US20040192680A1 (en) * 2002-12-20 2004-09-30 Anderson Steven N. Novel amides that activate soluble guanylate cyclase
DE102005031575A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Förderung der Wundheilung

Also Published As

Publication number Publication date
CL2008002942A1 (es) 2009-06-05
CA2706241A1 (en) 2009-04-09
AU2008306207A1 (en) 2009-04-09
US8518998B2 (en) 2013-08-27
CN101815514B (zh) 2012-05-09
ES2527948T3 (es) 2015-02-02
IL204668A0 (en) 2010-11-30
EP2207541A1 (en) 2010-07-21
AR071049A1 (es) 2010-05-26
IL204668A (en) 2013-10-31
TW200932247A (en) 2009-08-01
JP2010540581A (ja) 2010-12-24
KR20100063109A (ko) 2010-06-10
WO2009043495A1 (en) 2009-04-09
PA8797801A1 (es) 2009-06-23
HK1143756A1 (en) 2011-01-14
CN101815514A (zh) 2010-08-25
US20110021505A1 (en) 2011-01-27
EP2207541B1 (en) 2014-10-29
JP5487107B2 (ja) 2014-05-07
CA2706241C (en) 2015-12-22
BRPI0817483A2 (pt) 2016-07-26
PE20090961A1 (es) 2009-08-10

Similar Documents

Publication Publication Date Title
WO2011044506A3 (en) Sulphone compounds for use in the treatment of obesity
GEP20166443B (en) Heterocyclic compound and use thereof
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
GB0625648D0 (en) Compounds
IN2012DN01233A (es)
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
MX2009013935A (es) Compuestos quimicos.
WO2010007116A3 (en) Pyridons as pdk1 inhibitors
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
PH12012500620A1 (en) Compounds
NZ601483A (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2010093849A3 (en) Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
SI2150530T1 (sl) Substituirani sulfonamidni derivati
TN2012000062A1 (en) Jak 2 inhibitors and their use for the treatment of myeloproliferative deseases and cancer
MY176944A (en) Substituted pyrimidines for the treatment of diseases such as cancer
MX2009007231A (es) Compuestos quimicos 637:piridopirimidindionas como inhibidores de la fosfodiesterasa 4.
MX2010003071A (es) Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor.
NZ600874A (en) Fluorinated derivatives of deferiprone
EA201100255A1 (ru) 5-алкинилпиримидины
MX2010006108A (es) Inhibidores de estearoil-coa-desaturasa.
TW200630374A (en) Thiazolyldihydroindazoles
EA201100872A1 (ru) Производные хиназолинамида
MX2011011080A (es) Antagonistas de ccr3 de arilsulfonamida 2, 5-disustituida.
MX2010009837A (es) Tiazolil-dihidro-indazoles.
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure

Legal Events

Date Code Title Description
FG Grant or registration